Susan M Thompson, NP Nurse Practitioner - Family Medicare: Not Enrolled in Medicare Practice Location: 162 S Dalton St, Slocomb, AL 36375 Phone: 334-886-3023 Fax: 334-886-3028 |
Kelli Lynn Mcallister, FNP-BC Nurse Practitioner - Family Medicare: Medicare Enrolled Practice Location: 7483 S County Road 49, Slocomb, AL 36375 Phone: 334-701-5355 |
Dana Marie Register, NP Nurse Practitioner - Primary Care Medicare: Not Enrolled in Medicare Practice Location: 11119 S County Road 49, Slocomb, AL 36375 Phone: 334-405-2912 |
News Archive
When proteins misfold, accumulate and clump around insulin-producing cells in the pancreas, they kill cells. Now, researchers, including University of Michigan biophysicists, have obtained a structural snapshot of these proteins when they are most toxic, detailing them down to the atomic level.
A new study in the American Journal of Preventive Medicine finds that many smokers still find accurate and detailed facts about the dangers of tobacco both new and motivating in terms of their desire to quit. This finding proved to be especially marked among members of groups that are most likely to be smokers today.
MMR Information Systems, Inc. (OTCBB: MMRF) (the "Company"), which through its wholly-owned operating subsidiary, MyMedicalRecords, Inc. ("MMR"), provides consumer-controlled Personal Health Records ("PHRs") (www.mymedicalrecords.com) and electronic safe deposit box storage solutions (www.myesafedepositbox.com), announced that it has launched its MyMedicalRecords Pro ("MMRPro") product which is designed to help doctors take the first steps towards an EMR system by digitizing medical records and making them available to patients through a patient portal that incorporates the MyMedicalRecords.com Personal Health Record.
Nektar Therapeutics today announced positive results from a Phase 2 clinical study evaluating single-agent NKTR-102 in patients with metastatic breast cancer during the 33rd Annual CTRC-AACR San Antonio Breast Cancer Symposium (SABCS). NKTR-102, a novel investigational topoisomerase I inhibitor-polymer conjugate, is Nektar's lead oncology candidate and is being evaluated in multiple cancer indications.
More than half of the severe listeriosis cases in the European Union belong to clusters, many of which are not being picked up fast enough by the current surveillance system, suggests a new article published in Eurosurveillance.
› Verified 1 days ago